CVS Health

Integrated payer, PBM, and retail pharmacy (Aetna, Caremark, about 9,000 stores). Caremark holds the strongest single lever over US GLP-1 access: it made Wegovy the preferred weight-management drug from July 2025 and removed Zepbound, then added Zepbound back at the same tier effective October 1, 2026.